Key Takeaways
- Volume-led revenue dip, margin resilience: Sales volume fell 12.7% QoQ on seasonality and Thailand softness, yet PBDIT margin improved to 13.3% from 11.9% as product mix shifted toward higher-margin ABS.
- Thailand is a deliberate long play: The acquired asset ran at ~50% utilization and carries a brand-transition drag; management frames it as medium-to-long-term value, not a near-term earnings driver.
- India expansion on track, demand robust: ABS debottlenecking has already lifted volumes well above FY22 levels, Phase 1 capex is underway for FY27 completion, and domestic demand across appliances and auto is expected to stay healthy.
- Competitive narrative is steady: Management sees no significant increase in competitive intensity, believes global overcapacity is an old story it has already grown through, and notes domestic capacity additions now look lower than earlier industry views.
- What to watch next quarter: Whether polystyrene demand recovers as seasonality turns favorable in H2, any volume uptick from Thailand’s brand-conversion efforts, and concrete capex spend pacing toward the Phase 1 timeline.
Volume & Revenue Dynamics
- QoQ volume drop: Sales volume declined to 45.2 KT from 51.8 KT in Q1, driven by polystyrene flatness in household appliances and air conditioning, plus a sequential dip in Thailand.
- YoY volume growth intact: Volumes still grew 8.1% YoY against 41.8 KT in Q2 FY25, with most of the H1 growth coming from ABS rather than polystyrene.
- Revenue pass-through effect: Revenue fell 14.7% QoQ and 5.8% YoY, amplified by the pass-through of lower styrene and acrylonitrile prices under formula-based customer contracts.
- Gross spread improvement: Despite declining raw material prices, gross spreads improved QoQ because ABS, which carries higher margins, formed a larger percentage of the volume mix this quarter.
- Inventory impact minimal: The company does not carry large inventory in India, so styrene monomer price movements did not create material inventory gains or losses; acrylonitrile and butadiene are smaller components.
- Polystyrene recovery expected: PS demand was muted in H1 on seasonality; management expects the next six months to be better, with cover-up in Q3 and Q4 as the segment typically runs fuller in those quarters.
Agrawal: "I have always stated that as far as the... value which will come from Thailand is a significant long-term value. And that is for most shareholders, I think that is of vital importance."
Thailand Integration
- Utilization is the core challenge: The plant ran at ~50% capacity in H1 (32 KT against 120 KT annual nameplate), and management flagged low utilization as the single biggest headwind.
- Brand transition underway: The shift from the INEOS brand to Absolac caused an estimated 5–10% volume loss, which management expects to recover as the new brand gains recognition in the region.
- No near-term EBITDA contribution: Thailand will not significantly contribute to consolidated results in the near term; improvement in productivity, technology and sales will be stepwise and gradual.
- Headcount stable, not cut: No headcount reduction occurred post-acquisition; in fact, some salespeople were added, and the net cost impact is not significant.
- Product mix unchanged: The plant produces only ABS and SAN, with no polystyrene, and the mix remains similar to pre-acquisition levels.
- New customers added, volumes lag: Some new customers have been brought in but have not yet translated into large volumes; management anticipates flat H2 volumes versus H1, with an uptick only next year.
Agrawal: "…there is a way of working in that region, which we need to respect. And we need to be able to ensure that the kind of the asset is able to deliver how we want in the long term as opposed to looking for short-term gains."
India Demand & End-Market Outlook
- Demand expected robust: Management sees appliances (refrigerators), auto, and small appliances all improving; a GST cut is anticipated to provide some benefit, though timing is uncertain.
- Auto growth sustained: Auto growth is expected to remain robust, with Q4 typically strong and both four-wheeler and two-wheeler segments showing reasonably good growth next quarter.
- ABS running full: ABS capacity utilization is relatively full and management anticipates no challenge in utilizing the entire capacity until new capacity comes online.
- Volume growth target: Management anticipates roughly 10% volume growth for the full year, with the second half expected to be a little better than the first half, though this is not a formal commitment.
- Competitive intensity stable: No significant increase in competitive intensity has been observed so far, and no material change in the ABS margin profile; management will watch how dynamics evolve as new domestic capacity comes on stream.
Expansion & Capex
- Phase 1 ABS capex on schedule: Phase 1 of ABS capacity augmentation is progressing as planned and will be completed during FY27, likely between the middle and the end of the financial year.
- Capex spend envelope: The INR 350 crores Phase 1 capex will be spent within two years, with spending already underway.
- Debottlenecking track record: ABS volumes have already risen from ~60,000 tonnes/year in FY22 to ~90,000–100,000 tonnes last year and higher this year; PS volumes similarly increased from ~40,000–45,000 tonnes to higher levels.
- IRR acceptable: Management stated the Board has cleared capex investments at a reasonably acceptable and healthy IRR.
- No mass ABS demand yet: Management has not received any demand from auto OEMs for mass ABS, a product grade some peers produce.
Strategic Moves & Competitive Positioning
- Dubai subsidiary incorporated: Styrenix Performance Materials FZE was set up in Jafza, Dubai in September 2024 as a base for sales to the Middle East, Europe and the US, and as a holding entity for tax and operational efficiency; no transactions occurred during the quarter.
- Regional sales footprint expanding: New offices opened in Vietnam, with marketing representatives now in Japan, Korea and Indonesia, adding to the existing Shanghai presence.
- Dubai/GCC sales timeline: Real benefit from operating leverage and capacity utilization will come when Indian volumes are leaner, likely next year rather than in the next few quarters; realizations are better in India than in GCC markets.
- Global overcapacity managed: Management noted global overcapacity has existed for some time and the company has still managed to increase its business; it believes it will remain relevant and maintain leadership in segments where it is better equipped to produce.
- Domestic capacity view moderating: Based on recent commentary from the three domestic players, overall capacity additions now look lower than earlier industry views, which supports the import-substitution thesis.
Agrawal: "…there is already overcapacity globally, but that's not today or tomorrow. It has been there for quite some time since we have taken over, in fact, or even before that. And in the context of that, I think we have still managed to increase our business."
Balance Sheet & Working Capital
- Working capital increased: INR 90 crores was utilized for working capital due to inventory build-up from running the Thailand plant at full pace for 2–3 months to test capacity; this inventory will be utilized in future periods.
- Creditor reduction: Standalone creditors reduced by INR 180 crores due to optimization of buying patterns and timing of vessel arrivals and payments.
- Management bandwidth priorities: Leadership is focused on brownfield expansion execution in India, increasing Thailand sales and synergies, augmenting capabilities in sales, projects, supply chain and R&D, and new product and grade development.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| India volume growth | Expanded capacities to translate into sales; reasonable growth over last year | Full year FY26 |
| Polystyrene recovery | Cover-up expected as PS typically runs fuller in Q3 and Q4 | H2 FY26 (Q3 and Q4) |
| ABS capacity utilization | Running relatively full; no challenge utilizing entire capacity until new capacity comes online | Until Phase 1 completion |
| Phase 1 ABS capex completion | INR 350 crores capex, capacity augmentation | FY27, between middle and end of financial year |
| Thailand volumes | Flat in H2 vs H1; some uptick next year | H2 FY26 flat; growth from FY27 |
| Thailand capacity utilization | Medium to long term, significantly higher than today | No date given |
| Dubai/GCC sales contribution | Real benefit when Indian volumes are leaner | Likely next year, not next few quarters |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Stand-alone revenue | ₹615 cr, down 14.7% QoQ and down 5.8% YoY |
| Stand-alone PBDIT | ₹81.8 cr (13.3% margin), vs ₹86.1 cr (11.9%) in Q1 FY26 and ₹105.2 cr (15.9%) in Q2 FY25 |
| Stand-alone sales volume | 45.2 KT, down 12.7% QoQ and up 8.1% YoY |
| Consolidated revenue | ₹799 cr, down 15.32% QoQ |
| Consolidated PBDIT | ₹88.4 cr (11.1% margin), vs ₹99 cr (10.6%) in Q1 FY26 |
| Consolidated sales volume | 57.5 KT, down 14.4% QoQ |
| H1 FY26 stand-alone revenue | ₹1,336 cr, down 1.18% YoY |
| H1 FY26 stand-alone PBDIT | ₹167.9 cr (12.6% margin), lower by 1.9% YoY |
| H1 FY26 stand-alone sales volume | 97 KT, up 7.6% YoY |
| H1 FY26 consolidated revenue | ₹1,742 cr |
| H1 FY26 consolidated PBDIT | ₹188 cr (10.8% margin) |
| H1 FY26 consolidated sales volume | 124.7 KT |
| Thailand H1 FY26 volume | ~32 KT (17 KT in Q1, 15 KT in Q2), full year expected flattish |
| Thailand capacity utilization | ~50% (32 KT in H1 vs ~120 KT annual capacity) |
| Phase 1 ABS capex plan | ~₹350 cr, spending through next financial year; H1 FY26 consolidated capex spent ₹75 cr |
| Total loans | ~₹120 cr working capital and other loans, plus a separate acquisition loan |
| Thailand headcount | ~164 people |
| Thailand market share | ~10% of Thailand market; 90% of business retained post-acquisition |